332 related articles for article (PubMed ID: 18457460)
21. Proton pump inhibitors--uncommon adverse effects.
Oh S
Aust Fam Physician; 2011 Sep; 40(9):705-8. PubMed ID: 21894279
[TBL] [Abstract][Full Text] [Related]
22. Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications.
Robinson M
Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():1-10. PubMed ID: 15496213
[TBL] [Abstract][Full Text] [Related]
23. Proton pump inhibitors (PPIs) may cause gastric cancer - clinical consequences.
Waldum HL; Sørdal Ø; Fossmark R
Scand J Gastroenterol; 2018 Jun; 53(6):639-642. PubMed ID: 29852782
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
Huang JQ; Hunt RH
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
[TBL] [Abstract][Full Text] [Related]
25. Proton pump inhibitors and gastric neoplasia.
Kuipers EJ
Gut; 2006 Sep; 55(9):1217-21. PubMed ID: 16905689
[TBL] [Abstract][Full Text] [Related]
26. Use of proton pump inhibitors in adults in France: a nationwide drug utilization study.
Lassalle M; Le Tri T; Bardou M; Biour M; Kirchgesner J; Rouby F; Dumarcet N; Zureik M; Dray-Spira R
Eur J Clin Pharmacol; 2020 Mar; 76(3):449-457. PubMed ID: 31838548
[TBL] [Abstract][Full Text] [Related]
27. Potassium-competitive acid blockers: Advanced therapeutic option for acid-related diseases.
Inatomi N; Matsukawa J; Sakurai Y; Otake K
Pharmacol Ther; 2016 Dec; 168():12-22. PubMed ID: 27514776
[TBL] [Abstract][Full Text] [Related]
28. Results of short-and long-term medical treatment of gastroesophageal reflux disease (GERD).
Pohle T; Domschke W
Langenbecks Arch Surg; 2000 Aug; 385(5):317-23. PubMed ID: 11026702
[TBL] [Abstract][Full Text] [Related]
29. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
Brusselaers N; Wahlin K; Engstrand L; Lagergren J
BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
[TBL] [Abstract][Full Text] [Related]
30. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
;
Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
[TBL] [Abstract][Full Text] [Related]
31. Effects of proton pump inhibitors on gastric emptying: a systematic review.
Sanaka M; Yamamoto T; Kuyama Y
Dig Dis Sci; 2010 Sep; 55(9):2431-40. PubMed ID: 20012198
[TBL] [Abstract][Full Text] [Related]
32. [New-generation proton pump inhibitors: progress in the treatment of peptic acid diseases?].
de Korwin JD; Ducrotté P; Vallot T
Presse Med; 2004 Jun; 33(11):746-54. PubMed ID: 15257232
[TBL] [Abstract][Full Text] [Related]
33. The effect of proton pump inhibitors on the gastric mucosal microenvironment.
Peng YC; Huang LR; Ho HC; Chang CS; Lee SW; Cheng CC; Wen MC; Yeh HZ; Ho SP
Adv Clin Exp Med; 2017; 26(1):39-43. PubMed ID: 28397430
[TBL] [Abstract][Full Text] [Related]
34. The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal.
Savarino V; Dulbecco P; de Bortoli N; Ottonello A; Savarino E
Eur J Intern Med; 2017 Jan; 37():19-24. PubMed ID: 27784575
[TBL] [Abstract][Full Text] [Related]
35. Proton pump inhibitors: actions and reactions.
Mullin JM; Gabello M; Murray LJ; Farrell CP; Bellows J; Wolov KR; Kearney KR; Rudolph D; Thornton JJ
Drug Discov Today; 2009 Jul; 14(13-14):647-60. PubMed ID: 19443264
[TBL] [Abstract][Full Text] [Related]
36. Proton pump inhibitors for gastroduodenal damage related to nonsteroidal anti-inflammatory drugs or aspirin: twelve important questions for clinical practice.
Arora G; Singh G; Triadafilopoulos G
Clin Gastroenterol Hepatol; 2009 Jul; 7(7):725-35. PubMed ID: 19306941
[TBL] [Abstract][Full Text] [Related]
37. Proton-Potassium (H(+)/K(+)) ATPases: Properties and Roles in Health and Diseases.
Sakai H; Fujii T; Takeguchi N
Met Ions Life Sci; 2016; 16():459-83. PubMed ID: 26860309
[TBL] [Abstract][Full Text] [Related]
38. Effect of long-term proton pump inhibitor administration on gastric mucosal atrophy: A meta-analysis.
Li Z; Wu C; Li L; Wang Z; Xie H; He X; Feng J
Saudi J Gastroenterol; 2017; 23(4):222-228. PubMed ID: 28721975
[TBL] [Abstract][Full Text] [Related]
39. Therapy for peptic ulcer disease.
Lukáš M
Vnitr Lek; 2018; 64(6):595-599. PubMed ID: 30223656
[TBL] [Abstract][Full Text] [Related]
40. [Nonsteroidal Anti-inflammatory Drug and Aspirin-induced Peptic Ulcer Disease].
Shim YK; Kim N
Korean J Gastroenterol; 2016 Jun; 67(6):300-12. PubMed ID: 27312830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
